India's Drug Regulator Cracks Down on Illegal Weight Loss Drug Sales

India's national drug regulator has intensified its vigil on the supply chain of GLP-1-based weight loss medications following reports of unauthorised sales. The Central Drugs Standard Control Organisation conducted coordinated inspections at 49 sites, including online pharmacies and clinics, to secure the distribution channels. In a parallel action, the Drug Controller General of India launched a nationwide crackdown on unapproved Fixed Dose Combinations. Medical experts warn that these powerful drugs must only be used under strict medical supervision due to potential side effects.

Key Points: Drug Regulator Inspects 49 Sites Over Weight Loss Drug Sales

  • Nationwide inspections at 49 sites
  • Crackdown on unauthorised GLP-1 drug sales
  • Advisory against public promotion of prescription drugs
  • Parallel action on unapproved Fixed Dose Combinations
2 min read

Drug regulator inspects 49 entities over unauthorised sale of weight loss drugs

CDSCO intensifies vigil on GLP-1 weight loss drugs after inspections at 49 entities. Experts warn against reckless use of these powerful medications.

"One should not consume it (generic semaglutide) recklessly as these are serious medicines for a serious problem. - Dr Nikhil Tandon"

New Delhi, March 24

The national drug regulator on Tuesday intensified its vigil on the supply chain of GLP-1-based weight loss medications following reports of unauthorised sales and misuse. The move comes after the drug regulator conducted coordinated inspections at 49 different sites, including online pharmacies, wholesalers, and wellness clinics across the country.

The action aims to secure the supply chain and ensure these specialised drugs are not distributed through illegal channels.

Recently, the Central Drugs Standard Control Organisation (CDSCO) issued a strict advisory warning pharmaceutical companies against promoting prescription weight drugs to the general public. Doctors say this diktat must be followed by all.

On the other hand, on Monday, the Drug Controller General of India (DCGI) launched a nationwide crackdown on unapproved Fixed Dose Combination (FDCs). The drug regulator has requested to examine the 90 FDCs in the generic name, whether approval is granted by the state or UT drug controllers, according to a letter accessed by ANI.

These drugs include Multi vitamins, folic acids, syrups, Paracetamol, Clotrimazole and Betamethasone Cream, Diclofenac Potassium and Dicyclomine Hydrochloride Tablets, etc.

Meanwhile, the generic GLP-1 has entered the Indian market at a huge discount compared to innovator products already available, according to an expert from AIIMS, Dr Nikhil Tandon, professor and HOD of the Department of Endocrinology and Metabolism.

Dr Nikhil Tandon told ANI, "One should not consume it (generic semaglutide) recklessly as these are serious medicines for a serious problem. People should be careful, as there can be side effects."

On GLP-1, he said, "The GLP-1 was initially used for diabetic management but was later found to have an impact on weight."

Earlier, Dr V Mohan, renowned diabetologist and Chairman of Dr Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, said, "Strict pharmacovigilance must be maintained."

"While they are very effective and fairly safe, side effects can occur, but more Indian data needs to be collected."

He further said that these drugs must be prescribed by qualified doctors. "This will make it accessible to many more people, and quality is important. People are advised to strictly use these drugs under the advice and supervision of a doctor, as these drugs can these drugs are very powerful and can produce side effects in some people," he said.

- ANI

Share this article:

Reader Comments

R
Rohit P
While the action is good, I hope it doesn't make it harder for genuine patients who need these drugs for diabetes or obesity management. The key is regulation, not restriction. The generic versions at lower cost could be a game-changer if monitored properly.
D
David E
The online pharmacy scene in India is a wild west. You can get almost anything without a proper prescription. Inspecting 49 entities is a start, but they need to do this continuously. Public awareness is also crucial.
A
Ananya R
Dr. Tandon and Dr. Mohan are absolutely right. These are serious medicines. In our culture, there's so much pressure to be slim, especially on women. People are risking their health for quick fixes. Strict pharmacovigilance is a must.
M
Michael C
I have a respectful criticism. The article mentions a crackdown on unapproved FDCs, which includes common things like Paracetamol. This is important, but I hope the regulator's focus remains sharp on the high-risk weight loss drugs and doesn't get diluted.
K
Karthik V
The wellness clinics are a big part of the problem. They prescribe these drugs like candy. My cousin went to one and got a prescription for a GLP-1 drug after just a 5-minute consultation. No proper tests, nothing. This action was needed urgently.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50